Liquid botulinum toxin formulation and use thereof
AssigneeMERZ PHARMA GmbH & CO. KGaA
InventorsKarl-Heinz EISELE, Klaus FINK, Harold V. TAYLOR, Claudia JATZKE, Katja KÜHBACH
Life of this patent
Estimating the term…
Loading patent…
AssigneeMERZ PHARMA GmbH & CO. KGaA
InventorsKarl-Heinz EISELE, Klaus FINK, Harold V. TAYLOR, Claudia JATZKE, Katja KÜHBACH
Estimating the term…
The present invention relates to a liquid formulation comprising (i) botulinum toxin, (ii) human serum albumin (HSA), and optionally (iii) a tonicity agent and/or (iv) a buffering agent. In one aspect, the liquid formulation is characterized by a very low iron ion concentration. In another aspect, liquid formulation is characterized by the absence or very low concentration of tryptophan and/or N-acetyl-tryptophan. According to the present invention, the liquid formulation can be prepared by a method comprising the steps of contacting human serum albumin with a chelating agent to obtain a mixture and removing the chelating agent from the mixture. Furthermore, the present invention relates to the use of the liquid formulation in the treatment of therapeutic indications and cosmetic conditions.
-15. (canceled)
A liquid formulation, comprising
A liquid formulation, comprising
A liquid formulation, comprising
Dependencies are inferred from the claim text.